Literature DB >> 18537006

Autoimmune hemolytic anemia.

V Gupta1, J Shukla, B D Bhatia.   

Abstract

OBJECTIVE: To study the clinico-hematological profile and treatment outcome in children suffering from auto immune hemolytic anemia (AIHA).
METHODS: Twelve children were diagnosed with auto immune hemolytic anemia over a period of four years. Direct antiglobulin test was positive in all the cases. Other causes of hemolytic anemia like thalassemia syndromes, hereditary spherocytosis, G6PD deficiency were excluded by appropriate tests. The children were followed up for 6 months to 4 years.
RESULTS: The age ranged from 7 mth to 9 yr with a mean age of 4.51 yr. All patients had pallor as the presenting complaint followed by splenomegaly (83.3%), jaundice (66.7%), fever (50%) and bleeding manifestations (16.7%). 9 patients had primary disease and 3 had secondary disease. Tubercular infection was seen in 2 patients with secondary disease. Jaundice was seen equally in both the groups. Oral prednisolone produced remission in 83.3% cases. 4 patients (3 in primary and one in secondary group) had relapse after initial response. All responded to a second course of steroids but had subsequent relapses and developed a chronic course.
CONCLUSION: Autoimmune hemolytic anemia is an uncommon cause of hemolytic anemia in children. Tubercular infection is an underlying pathology in cases of secondary autoimmune hemolytic anemia. Although oral steroids induce remission in most of the cases, relapses are common.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537006     DOI: 10.1007/s12098-008-0071-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  16 in total

1.  Autoimmune hemolytic anemia in visceral leishmaniasis.

Authors:  S N Adil; I A Burney; M Khurshid
Journal:  J Pak Med Assoc       Date:  1999-04       Impact factor: 0.781

2.  Autoimmune hemolytic anemia associated with Crohn's disease.

Authors:  Jay A Hochman
Journal:  Inflamm Bowel Dis       Date:  2002-03       Impact factor: 5.325

3.  High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

Authors:  Victor M Moyo; Douglas Smith; Isadore Brodsky; Pamela Crilley; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

4.  Autoimmune hemolytic anemia in childhood: serologic features in 100 cases.

Authors:  Stefania Vaglio; Maria Cristina Arista; Maria Paola Perrone; Gabriella Tomei; Anna Maria Testi; Serelina Coluzzi; Gabriella Girelli
Journal:  Transfusion       Date:  2007-01       Impact factor: 3.157

5.  Clinical course of autoimmune hemolytic anemia: an observational study.

Authors:  Maria Christina L A Oliveira; Benigna M Oliveira; Mitiko Murao; Zilma Maria Vieira; Letícia T Gresta; Marcos B Viana
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

6.  Clinico-hematological spectrum of auto-immune hemolytic anemia: an Indian experience.

Authors:  V P Choudhry; G R Passi; H P Pati
Journal:  J Assoc Physicians India       Date:  1996-02

7.  Abdominal tuberculosis with autoimmune hemolytic anemia.

Authors:  V Gupta; B D Bhatia
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

8.  Factors influencing prognosis in childhood autoimmune hemolytic anemia.

Authors:  M A Heisel; J A Ortega
Journal:  Am J Pediatr Hematol Oncol       Date:  1983

Review 9.  Autoimmune hemolytic anemia complicating disseminated childhood tuberculosis.

Authors:  Sameer Bakhshi; I Satish Rao; Vandana Jain; L S Arya
Journal:  Indian J Pediatr       Date:  2004-06       Impact factor: 1.967

10.  Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.

Authors:  Nick G Gottardo; David L Baker; Frank R Willis
Journal:  Pediatr Hematol Oncol       Date:  2003 Oct-Nov       Impact factor: 1.969

View more
  7 in total

1.  Rituximab in steroid refractory autoimmune hemolytic anemia.

Authors:  Nitin Gupta; Sanjeev Sharma; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra; Suman Kumar; Rajan Kapoor; Narendra Agarwal
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

2.  Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment.

Authors:  Quentin A Hill; Anita Hill; Sigbjørn Berentsen
Journal:  Blood Adv       Date:  2019-06-25

3.  Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.

Authors:  Saverio Ladogana; Matteo Maruzzi; Piera Samperi; Silverio Perrotta; Giovanni C Del Vecchio; Lucia D Notarangelo; Piero Farruggia; Federico Verzegnassi; Nicoletta Masera; Paola Saracco; Silvia Fasoli; Maurizio Miano; Gabriella Girelli; Wilma Barcellini; Alberto Zanella; Giovanna Russo
Journal:  Blood Transfus       Date:  2016-12-16       Impact factor: 3.443

Review 4.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

5.  The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Authors:  Ibrahim Ahmed; Jun Teruya; Cristina Murray-Krezan; Robert Krance
Journal:  Pediatr Transplant       Date:  2015-03-23

6.  Autoimmune hemolytic anemia: mixed type-a case report.

Authors:  V R Sudha Reddy; Purnima Samayam; B Ravichander; Uma Bai
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-07       Impact factor: 0.900

7.  A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy.

Authors:  N S Ghadyalpatil; R Chandrasekar; D Snehalatha; B M Reddy
Journal:  Indian J Med Paediatr Oncol       Date:  2011-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.